U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07826455) titled 'A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERD' on Sept. 13.
Brief Summary: The purpose of this study is to evaluate the diagnostic value of tegoprazan for GERD.
Patients experiencing typical GERD symptoms, such as heartburn and acid regurgitation, will take either tegoprazan or a placebo once daily for 1 week.
Investigators will compare the short-term symptom improvement between the two groups to determine if an early response to tegoprazan can help diagnose GERD.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
GERD (Gastroesophageal Reflux Disease)
Intervention:
DRUG: Tegoprazan 50 mg
Tegop...